Published in Circulation on July 24, 2001
Can we still rely on the ECG for detecting past myocardial injury? JACC Cardiovasc Imaging (2013) 2.02
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J (2009) 1.92
Prediction and prevention of sudden cardiac death in heart failure. Heart (2005) 1.29
Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging. Heart (2007) 0.93
Analysis of speed, curvature, planarity and frequency characteristics of heart vector movement to evaluate the electrophysiological substrate associated with ventricular tachycardia. Comput Biol Med (2015) 0.87
Fragmented QRS: What Is The Meaning? Indian Pacing Electrophysiol J (2012) 0.86
Electrophysiological effects of late percutaneous coronary intervention for infarct-related coronary artery occlusion: the Occluded Artery Trial-Electrophysiological Mechanisms (OAT-EP). Circulation (2009) 0.83
Surface Electrocardiogram Predictors of Sudden Cardiac Arrest. Ochsner J (2016) 0.82
Risk stratification for sudden cardiac death: current approaches and predictive value. Curr Cardiol Rev (2009) 0.82
Is T-wave alternans as good or better than programmed ventricular stimulation? Heart Rhythm (2007) 0.78
New methods for the analysis of heartbeat behavior in risk stratification. Front Physiol (2011) 0.78
Electrocardiographic left ventricular hypertrophy predicts arrhythmia and mortality in patients with ischemic cardiomyopathy. J Interv Card Electrophysiol (2012) 0.78
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). Am J Cardiol (2007) 0.77
Frequency content and characteristics of ventricular conduction. J Electrocardiol (2015) 0.77
Sudden cardiac arrest in patients with preserved left ventricular systolic function: a clinical dilemma. Heart Rhythm (2008) 0.77
Predictors of Sudden Cardiac Death in Doberman Pinschers with Dilated Cardiomyopathy. J Vet Intern Med (2016) 0.75
Incidence of Idiopathic Ventricular Arrhythmias: A Population-Based Study. Circ Arrhythm Electrophysiol (2017) 0.75
The future of implantable defibrillator and cardiac resynchronization therapy trials. J Interv Card Electrophysiol (2008) 0.75
[Ventricular tachycardia in postinfarction patients and coronary heart disease. Treatment and prognostic significance]. Herzschrittmacherther Elektrophysiol (2014) 0.75
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Evaluating the yield of medical tests. JAMA (1982) 14.05
An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia (1975) 11.53
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Clinical judgment and statistics. Lessons from a simulated randomized trial in coronary artery disease. Circulation (1980) 7.96
Regression modelling strategies for improved prognostic prediction. Stat Med (1984) 7.09
Use of medical resources and quality of life after acute myocardial infarction in Canada and the United States. N Engl J Med (1994) 6.78
Value of the history and physical in identifying patients at increased risk for coronary artery disease. Ann Intern Med (1993) 5.59
A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol (1989) 5.50
The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg (1991) 4.53
Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst (1988) 4.07
Infantile diarrhea produced by heat-stable enterotoxigenic Escherichia coli. N Engl J Med (1976) 3.82
Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med (1995) 3.69
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation (2000) 3.61
Referral patterns for coronary artery disease treatment: gender bias or good clinical judgment? Ann Intern Med (1992) 3.39
Job strain and the prevalence and outcome of coronary artery disease. Circulation (1995) 3.22
Electrocardiographic criteria for ventricular tachycardia in wide complex left bundle branch block morphology tachycardias. Am J Cardiol (1988) 3.18
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med (1987) 3.04
Clinical data bases. Accomplishments and unrealized potential. Med Care (1985) 2.83
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
Regression models for prognostic prediction: advantages, problems, and suggested solutions. Cancer Treat Rep (1985) 2.76
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery. J Am Coll Cardiol (1988) 2.59
Patient-specific predictions of outcomes in myocardial infarction for real-time emergency use: a thrombolytic predictive instrument. Ann Intern Med (1997) 2.52
Characterization of cDNA sequences corresponding to three distinct HMG-1 mRNA species in line CHO Chinese hamster cells and cell cycle expression of the HMG-1 gene. Nucleic Acids Res (1987) 2.51
The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. J Thorac Cardiovasc Surg (1991) 2.42
The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA (1989) 2.33
Clinical trials in acute myocardial infarction: should we adjust for baseline characteristics? Am Heart J (2000) 2.21
Amiodarone pulmonary toxicity. Ann Intern Med (1982) 2.16
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation (1998) 2.09
Polymorphic ventricular tachycardia induced by programmed stimulation: response to procainamide. J Am Coll Cardiol (1993) 2.08
Mitral valve prolapse. Circulation (1976) 2.05
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators. Circulation (1996) 2.03
The last word on GUSTO, for now. Ann Intern Med (1994) 2.02
Risk stratification and therapeutic decision making in acute coronary syndromes. JAMA (2000) 1.99
Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med (1987) 1.98
Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation (2000) 1.98
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation (1994) 1.91
Demonstration of a widely distributed atrial pacemaker complex in the human heart. Circulation (1988) 1.91
Time from symptom onset to treatment and outcomes after thrombolytic therapy. GUSTO-1 Investigators. J Am Coll Cardiol (1996) 1.91
Relationship between antecedent angina pectoris and short-term prognosis after thrombolytic therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J (1990) 1.90
Successful surgical treatment of atrial fibrillation. Review and clinical update. JAMA (1991) 1.89
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation (1996) 1.87
Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation (1999) 1.76
Nonfluoroscopic, in vivo navigation and mapping technology. Nat Med (1996) 1.76
The role of the exercise test in the evaluation of patients for ischemic heart disease. Circulation (1978) 1.75
Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol (1985) 1.71
Estimating the likelihood of significant coronary artery disease. Am J Med (1983) 1.69
The electrophysiology of propranolol in man. Am Heart J (1974) 1.67
Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: a statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology. J Am Coll Cardiol (1991) 1.63
Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics. Am J Med (1978) 1.62
Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol (1997) 1.62
Tying clinical research to patient care by use of an observational database. Stat Med (1985) 1.56
Type A behavior, hostility, and coronary atherosclerosis. Psychosom Med (1980) 1.55
Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation (1978) 1.54
Recurrent ischemia without warning. Analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation (1989) 1.54
Right ventricular tachycardia: clinical and electrophysiologic characteristics. Circulation (1983) 1.53
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators. Circulation (1998) 1.52
Induction of hepatic enzyme synthesis in vivo by adenosine 3', 5'-monophosphate. J Biol Chem (1969) 1.51
Effect of the implantable atrial defibrillator on the natural history of atrial fibrillation. J Cardiovasc Electrophysiol (1999) 1.50
Coronary-artery spasm immediately after myocardial revascularization: recognition and management. N Engl J Med (1981) 1.49
Endocardial activation of left bundle branch block. Circulation (1984) 1.49
An episode of ventricular tachycardia during long-duration spaceflight. Am J Cardiol (1998) 1.48
Reentrant and focal mechanisms underlying ventricular tachycardia in the human heart. Circulation (1992) 1.47
Survival in medically treated coronary artery disease. Circulation (1979) 1.46
Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation (1998) 1.45
Initiating reentry: the role of nonuniform anisotropy in small circuits. J Cardiovasc Electrophysiol (1994) 1.44
Endocardial excision: a new surgical technique for the treatment of recurrent ventricular tachycardia. Circulation (1979) 1.43
Presence and significance of the left atrionodal connection during atrioventricular nodal reentrant tachycardia. Am J Cardiol (1999) 1.43
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol (2001) 1.42
Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol (1983) 1.42
Long-term effectiveness of surgical treatment of ectopic atrial tachycardia. J Am Coll Cardiol (1993) 1.41
Entrainment of typical AV nodal reentrant tachycardia using para-Hisian pacing: evidence for a lower common pathway within the AV node. J Cardiovasc Electrophysiol (1999) 1.40
Bradycardic syncope in 2 patients who recently began gatifloxacin treatment. Clin Infect Dis (2003) 1.40
Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol (1979) 1.39
Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol (1979) 1.39
Atrioventricular nodal tachycardia occurring during atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.39
Failure of defibrillator paddle as mimic for subcutaneous patch lead during nonthoracotomy implantable cardioverter defibrillator lead configuration assessment. Pacing Clin Electrophysiol (1992) 1.39
Electrophysiologic properties of diphenylhydantoin. Circulation (1973) 1.38
Hybrid pharmacologic and ablative therapy: a novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol (1998) 1.36
Evaluation of patients with palpitations. N Engl J Med (1998) 1.36
Recurrent sustained ventricular tachycardia. 1. Mechanisms. Circulation (1978) 1.35
Electrophysiological evaluation of disopyramide in man. Am Heart J (1973) 1.34
Outcome in one-vessel coronary artery disease. Circulation (1983) 1.34
Electrophysiologic characteristics of Ebstein's anomaly of the tricuspid valve. Circulation (1975) 1.31
Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol (1986) 1.30
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in acute myocardial infarction. Circulation (1989) 1.30
Site-dependent intra-atrial conduction delay. Relationship to initiation of atrial fibrillation. Circulation (1996) 1.29
Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation (1978) 1.28
Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol (1987) 1.28
Changes in hepatic levels of tyrosine aminotransferase messenger RNA during induction by hydrocortisone. J Biol Chem (1978) 1.28
ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol (1998) 1.27
Ventricular resection guided by epicardial and endocardial mapping for treatment of recurrent ventricular tachycardia. N Engl J Med (1980) 1.26
Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol (1993) 1.25